Global Whole Genome and Exome Sequencing Market 2022 by Company, Regions, Type and Application, Forecast to 2028
Page: 103
Published Date: 12 Jan 2022
Category: Medical Care
PDF Download
Get FREE Sample
Customize Request
- Description
- Table of Contents
- Table of Figures
- Research Methodology
- Companies Mentioned
- Related Reports
- Product Tags
Description
The Whole Genome and Exome Sequencing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Whole Genome and Exome Sequencing market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals and Clinics accounting for % of the Whole Genome and Exome Sequencing global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While By Product segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Whole Genome and Exome Sequencing include Eurofins Scientific SE, Agilent Technologies, Inc, Beijing Genomics Institute (BGI), Hoffmann-La Roche Ltd, and Bio-Rad Laboratories, Inc, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Whole Genome and Exome Sequencing market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
By Product
Kits
Instruments
By Workflow
Whole Genome Sequencing (WGS)
Whole Exome Sequencing (WES)
Market segment by Application, can be divided into
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Diagnostic Labs
Research Centres, Academia and Government Institutes
Others
Market segment by players, this report covers
Eurofins Scientific SE
Agilent Technologies, Inc
Beijing Genomics Institute (BGI)
Hoffmann-La Roche Ltd
Bio-Rad Laboratories, Inc
GENEWIZ, Inc
Illumina, Inc
Laboratory Corporation of America Holdings
Novogene Corporation
Oxford Nanopore Technologies, Inc
Pacific Biosciences of California, Inc
QIAGEN N.V
Thermo Fisher Scientific Inc
Cytiva
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Whole Genome and Exome Sequencing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Whole Genome and Exome Sequencing, with revenue, gross margin and global market share of Whole Genome and Exome Sequencing from 2019 to 2022.
Chapter 3, the Whole Genome and Exome Sequencing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Whole Genome and Exome Sequencing market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Whole Genome and Exome Sequencing research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Whole Genome and Exome Sequencing
1.2 Classification of Whole Genome and Exome Sequencing by Type
1.2.1 Overview: Global Whole Genome and Exome Sequencing Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Whole Genome and Exome Sequencing Revenue Market Share by Type in 2021
1.2.3 Kits
1.2.4 Instruments
1.3 Global Whole Genome and Exome Sequencing Market by Application
1.3.1 Overview: Global Whole Genome and Exome Sequencing Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals and Clinics
1.3.3 Pharmaceutical and Biotechnology Companies
1.3.4 Diagnostic Labs
1.3.5 Research Centres, Academia and Government Institutes
1.3.6 Others
1.4 Global Whole Genome and Exome Sequencing Market Size & Forecast
1.5 Global Whole Genome and Exome Sequencing Market Size and Forecast by Region
1.5.1 Global Whole Genome and Exome Sequencing Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Whole Genome and Exome Sequencing Market Size by Region, (2017-2022)
1.5.3 North America Whole Genome and Exome Sequencing Market Size and Prospect (2017-2028)
1.5.4 Europe Whole Genome and Exome Sequencing Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Whole Genome and Exome Sequencing Market Size and Prospect (2017-2028)
1.5.6 South America Whole Genome and Exome Sequencing Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Whole Genome and Exome Sequencing Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Whole Genome and Exome Sequencing Market Drivers
1.6.2 Whole Genome and Exome Sequencing Market Restraints
1.6.3 Whole Genome and Exome Sequencing Trends Analysis
2 Company Profiles
2.1 Eurofins Scientific SE
2.1.1 Eurofins Scientific SE Details
2.1.2 Eurofins Scientific SE Major Business
2.1.3 Eurofins Scientific SE Whole Genome and Exome Sequencing Product and Solutions
2.1.4 Eurofins Scientific SE Whole Genome and Exome Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Eurofins Scientific SE Recent Developments and Future Plans
2.2 Agilent Technologies, Inc
2.2.1 Agilent Technologies, Inc Details
2.2.2 Agilent Technologies, Inc Major Business
2.2.3 Agilent Technologies, Inc Whole Genome and Exome Sequencing Product and Solutions
2.2.4 Agilent Technologies, Inc Whole Genome and Exome Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Agilent Technologies, Inc Recent Developments and Future Plans
2.3 Beijing Genomics Institute (BGI)
2.3.1 Beijing Genomics Institute (BGI) Details
2.3.2 Beijing Genomics Institute (BGI) Major Business
2.3.3 Beijing Genomics Institute (BGI) Whole Genome and Exome Sequencing Product and Solutions
2.3.4 Beijing Genomics Institute (BGI) Whole Genome and Exome Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Beijing Genomics Institute (BGI) Recent Developments and Future Plans
2.4 Hoffmann-La Roche Ltd
2.4.1 Hoffmann-La Roche Ltd Details
2.4.2 Hoffmann-La Roche Ltd Major Business
2.4.3 Hoffmann-La Roche Ltd Whole Genome and Exome Sequencing Product and Solutions
2.4.4 Hoffmann-La Roche Ltd Whole Genome and Exome Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Hoffmann-La Roche Ltd Recent Developments and Future Plans
2.5 Bio-Rad Laboratories, Inc
2.5.1 Bio-Rad Laboratories, Inc Details
2.5.2 Bio-Rad Laboratories, Inc Major Business
2.5.3 Bio-Rad Laboratories, Inc Whole Genome and Exome Sequencing Product and Solutions
2.5.4 Bio-Rad Laboratories, Inc Whole Genome and Exome Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Bio-Rad Laboratories, Inc Recent Developments and Future Plans
2.6 GENEWIZ, Inc
2.6.1 GENEWIZ, Inc Details
2.6.2 GENEWIZ, Inc Major Business
2.6.3 GENEWIZ, Inc Whole Genome and Exome Sequencing Product and Solutions
2.6.4 GENEWIZ, Inc Whole Genome and Exome Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 GENEWIZ, Inc Recent Developments and Future Plans
2.7 Illumina, Inc
2.7.1 Illumina, Inc Details
2.7.2 Illumina, Inc Major Business
2.7.3 Illumina, Inc Whole Genome and Exome Sequencing Product and Solutions
2.7.4 Illumina, Inc Whole Genome and Exome Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Illumina, Inc Recent Developments and Future Plans
2.8 Laboratory Corporation of America Holdings
2.8.1 Laboratory Corporation of America Holdings Details
2.8.2 Laboratory Corporation of America Holdings Major Business
2.8.3 Laboratory Corporation of America Holdings Whole Genome and Exome Sequencing Product and Solutions
2.8.4 Laboratory Corporation of America Holdings Whole Genome and Exome Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Laboratory Corporation of America Holdings Recent Developments and Future Plans
2.9 Novogene Corporation
2.9.1 Novogene Corporation Details
2.9.2 Novogene Corporation Major Business
2.9.3 Novogene Corporation Whole Genome and Exome Sequencing Product and Solutions
2.9.4 Novogene Corporation Whole Genome and Exome Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Novogene Corporation Recent Developments and Future Plans
2.10 Oxford Nanopore Technologies, Inc
2.10.1 Oxford Nanopore Technologies, Inc Details
2.10.2 Oxford Nanopore Technologies, Inc Major Business
2.10.3 Oxford Nanopore Technologies, Inc Whole Genome and Exome Sequencing Product and Solutions
2.10.4 Oxford Nanopore Technologies, Inc Whole Genome and Exome Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Oxford Nanopore Technologies, Inc Recent Developments and Future Plans
2.11 Pacific Biosciences of California, Inc
2.11.1 Pacific Biosciences of California, Inc Details
2.11.2 Pacific Biosciences of California, Inc Major Business
2.11.3 Pacific Biosciences of California, Inc Whole Genome and Exome Sequencing Product and Solutions
2.11.4 Pacific Biosciences of California, Inc Whole Genome and Exome Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Pacific Biosciences of California, Inc Recent Developments and Future Plans
2.12 QIAGEN N.V
2.12.1 QIAGEN N.V Details
2.12.2 QIAGEN N.V Major Business
2.12.3 QIAGEN N.V Whole Genome and Exome Sequencing Product and Solutions
2.12.4 QIAGEN N.V Whole Genome and Exome Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 QIAGEN N.V Recent Developments and Future Plans
2.13 Thermo Fisher Scientific Inc
2.13.1 Thermo Fisher Scientific Inc Details
2.13.2 Thermo Fisher Scientific Inc Major Business
2.13.3 Thermo Fisher Scientific Inc Whole Genome and Exome Sequencing Product and Solutions
2.13.4 Thermo Fisher Scientific Inc Whole Genome and Exome Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Thermo Fisher Scientific Inc Recent Developments and Future Plans
2.14 Cytiva
2.14.1 Cytiva Details
2.14.2 Cytiva Major Business
2.14.3 Cytiva Whole Genome and Exome Sequencing Product and Solutions
2.14.4 Cytiva Whole Genome and Exome Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Cytiva Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Whole Genome and Exome Sequencing Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Whole Genome and Exome Sequencing Players Market Share in 2021
3.2.2 Top 10 Whole Genome and Exome Sequencing Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Whole Genome and Exome Sequencing Players Head Office, Products and Services Provided
3.4 Whole Genome and Exome Sequencing Mergers & Acquisitions
3.5 Whole Genome and Exome Sequencing New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Whole Genome and Exome Sequencing Revenue and Market Share by Type (2017-2022)
4.2 Global Whole Genome and Exome Sequencing Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Whole Genome and Exome Sequencing Revenue Market Share by Application (2017-2022)
5.2 Global Whole Genome and Exome Sequencing Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Whole Genome and Exome Sequencing Revenue by Type (2017-2028)
6.2 North America Whole Genome and Exome Sequencing Revenue by Application (2017-2028)
6.3 North America Whole Genome and Exome Sequencing Market Size by Country
6.3.1 North America Whole Genome and Exome Sequencing Revenue by Country (2017-2028)
6.3.2 United States Whole Genome and Exome Sequencing Market Size and Forecast (2017-2028)
6.3.3 Canada Whole Genome and Exome Sequencing Market Size and Forecast (2017-2028)
6.3.4 Mexico Whole Genome and Exome Sequencing Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Whole Genome and Exome Sequencing Revenue by Type (2017-2028)
7.2 Europe Whole Genome and Exome Sequencing Revenue by Application (2017-2028)
7.3 Europe Whole Genome and Exome Sequencing Market Size by Country
7.3.1 Europe Whole Genome and Exome Sequencing Revenue by Country (2017-2028)
7.3.2 Germany Whole Genome and Exome Sequencing Market Size and Forecast (2017-2028)
7.3.3 France Whole Genome and Exome Sequencing Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Whole Genome and Exome Sequencing Market Size and Forecast (2017-2028)
7.3.5 Russia Whole Genome and Exome Sequencing Market Size and Forecast (2017-2028)
7.3.6 Italy Whole Genome and Exome Sequencing Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Whole Genome and Exome Sequencing Revenue by Type (2017-2028)
8.2 Asia-Pacific Whole Genome and Exome Sequencing Revenue by Application (2017-2028)
8.3 Asia-Pacific Whole Genome and Exome Sequencing Market Size by Region
8.3.1 Asia-Pacific Whole Genome and Exome Sequencing Revenue by Region (2017-2028)
8.3.2 China Whole Genome and Exome Sequencing Market Size and Forecast (2017-2028)
8.3.3 Japan Whole Genome and Exome Sequencing Market Size and Forecast (2017-2028)
8.3.4 South Korea Whole Genome and Exome Sequencing Market Size and Forecast (2017-2028)
8.3.5 India Whole Genome and Exome Sequencing Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Whole Genome and Exome Sequencing Market Size and Forecast (2017-2028)
8.3.7 Australia Whole Genome and Exome Sequencing Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Whole Genome and Exome Sequencing Revenue by Type (2017-2028)
9.2 South America Whole Genome and Exome Sequencing Revenue by Application (2017-2028)
9.3 South America Whole Genome and Exome Sequencing Market Size by Country
9.3.1 South America Whole Genome and Exome Sequencing Revenue by Country (2017-2028)
9.3.2 Brazil Whole Genome and Exome Sequencing Market Size and Forecast (2017-2028)
9.3.3 Argentina Whole Genome and Exome Sequencing Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Whole Genome and Exome Sequencing Revenue by Type (2017-2028)
10.2 Middle East & Africa Whole Genome and Exome Sequencing Revenue by Application (2017-2028)
10.3 Middle East & Africa Whole Genome and Exome Sequencing Market Size by Country
10.3.1 Middle East & Africa Whole Genome and Exome Sequencing Revenue by Country (2017-2028)
10.3.2 Turkey Whole Genome and Exome Sequencing Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Whole Genome and Exome Sequencing Market Size and Forecast (2017-2028)
10.3.4 UAE Whole Genome and Exome Sequencing Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Whole Genome and Exome Sequencing Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Whole Genome and Exome Sequencing Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Whole Genome and Exome Sequencing Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Whole Genome and Exome Sequencing Revenue (USD Million) by Region (2017-2022)
Table 5. Global Whole Genome and Exome Sequencing Revenue Market Share by Region (2023-2028)
Table 6. Eurofins Scientific SE Corporate Information, Head Office, and Major Competitors
Table 7. Eurofins Scientific SE Major Business
Table 8. Eurofins Scientific SE Whole Genome and Exome Sequencing Product and Solutions
Table 9. Eurofins Scientific SE Whole Genome and Exome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Agilent Technologies, Inc Corporate Information, Head Office, and Major Competitors
Table 11. Agilent Technologies, Inc Major Business
Table 12. Agilent Technologies, Inc Whole Genome and Exome Sequencing Product and Solutions
Table 13. Agilent Technologies, Inc Whole Genome and Exome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Beijing Genomics Institute (BGI) Corporate Information, Head Office, and Major Competitors
Table 15. Beijing Genomics Institute (BGI) Major Business
Table 16. Beijing Genomics Institute (BGI) Whole Genome and Exome Sequencing Product and Solutions
Table 17. Beijing Genomics Institute (BGI) Whole Genome and Exome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Hoffmann-La Roche Ltd Corporate Information, Head Office, and Major Competitors
Table 19. Hoffmann-La Roche Ltd Major Business
Table 20. Hoffmann-La Roche Ltd Whole Genome and Exome Sequencing Product and Solutions
Table 21. Hoffmann-La Roche Ltd Whole Genome and Exome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Bio-Rad Laboratories, Inc Corporate Information, Head Office, and Major Competitors
Table 23. Bio-Rad Laboratories, Inc Major Business
Table 24. Bio-Rad Laboratories, Inc Whole Genome and Exome Sequencing Product and Solutions
Table 25. Bio-Rad Laboratories, Inc Whole Genome and Exome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. GENEWIZ, Inc Corporate Information, Head Office, and Major Competitors
Table 27. GENEWIZ, Inc Major Business
Table 28. GENEWIZ, Inc Whole Genome and Exome Sequencing Product and Solutions
Table 29. GENEWIZ, Inc Whole Genome and Exome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Illumina, Inc Corporate Information, Head Office, and Major Competitors
Table 31. Illumina, Inc Major Business
Table 32. Illumina, Inc Whole Genome and Exome Sequencing Product and Solutions
Table 33. Illumina, Inc Whole Genome and Exome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Laboratory Corporation of America Holdings Corporate Information, Head Office, and Major Competitors
Table 35. Laboratory Corporation of America Holdings Major Business
Table 36. Laboratory Corporation of America Holdings Whole Genome and Exome Sequencing Product and Solutions
Table 37. Laboratory Corporation of America Holdings Whole Genome and Exome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Novogene Corporation Corporate Information, Head Office, and Major Competitors
Table 39. Novogene Corporation Major Business
Table 40. Novogene Corporation Whole Genome and Exome Sequencing Product and Solutions
Table 41. Novogene Corporation Whole Genome and Exome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Oxford Nanopore Technologies, Inc Corporate Information, Head Office, and Major Competitors
Table 43. Oxford Nanopore Technologies, Inc Major Business
Table 44. Oxford Nanopore Technologies, Inc Whole Genome and Exome Sequencing Product and Solutions
Table 45. Oxford Nanopore Technologies, Inc Whole Genome and Exome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Pacific Biosciences of California, Inc Corporate Information, Head Office, and Major Competitors
Table 47. Pacific Biosciences of California, Inc Major Business
Table 48. Pacific Biosciences of California, Inc Whole Genome and Exome Sequencing Product and Solutions
Table 49. Pacific Biosciences of California, Inc Whole Genome and Exome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. QIAGEN N.V Corporate Information, Head Office, and Major Competitors
Table 51. QIAGEN N.V Major Business
Table 52. QIAGEN N.V Whole Genome and Exome Sequencing Product and Solutions
Table 53. QIAGEN N.V Whole Genome and Exome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Thermo Fisher Scientific Inc Corporate Information, Head Office, and Major Competitors
Table 55. Thermo Fisher Scientific Inc Major Business
Table 56. Thermo Fisher Scientific Inc Whole Genome and Exome Sequencing Product and Solutions
Table 57. Thermo Fisher Scientific Inc Whole Genome and Exome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Cytiva Corporate Information, Head Office, and Major Competitors
Table 59. Cytiva Major Business
Table 60. Cytiva Whole Genome and Exome Sequencing Product and Solutions
Table 61. Cytiva Whole Genome and Exome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Global Whole Genome and Exome Sequencing Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 63. Global Whole Genome and Exome Sequencing Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 64. Breakdown of Whole Genome and Exome Sequencing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 65. Whole Genome and Exome Sequencing Players Head Office, Products and Services Provided
Table 66. Whole Genome and Exome Sequencing Mergers & Acquisitions in the Past Five Years
Table 67. Whole Genome and Exome Sequencing New Entrants and Expansion Plans
Table 68. Global Whole Genome and Exome Sequencing Revenue (USD Million) by Type (2017-2022)
Table 69. Global Whole Genome and Exome Sequencing Revenue Share by Type (2017-2022)
Table 70. Global Whole Genome and Exome Sequencing Revenue Forecast by Type (2023-2028)
Table 71. Global Whole Genome and Exome Sequencing Revenue by Application (2017-2022)
Table 72. Global Whole Genome and Exome Sequencing Revenue Forecast by Application (2023-2028)
Table 73. North America Whole Genome and Exome Sequencing Revenue by Type (2017-2022) & (USD Million)
Table 74. North America Whole Genome and Exome Sequencing Revenue by Type (2023-2028) & (USD Million)
Table 75. North America Whole Genome and Exome Sequencing Revenue by Application (2017-2022) & (USD Million)
Table 76. North America Whole Genome and Exome Sequencing Revenue by Application (2023-2028) & (USD Million)
Table 77. North America Whole Genome and Exome Sequencing Revenue by Country (2017-2022) & (USD Million)
Table 78. North America Whole Genome and Exome Sequencing Revenue by Country (2023-2028) & (USD Million)
Table 79. Europe Whole Genome and Exome Sequencing Revenue by Type (2017-2022) & (USD Million)
Table 80. Europe Whole Genome and Exome Sequencing Revenue by Type (2023-2028) & (USD Million)
Table 81. Europe Whole Genome and Exome Sequencing Revenue by Application (2017-2022) & (USD Million)
Table 82. Europe Whole Genome and Exome Sequencing Revenue by Application (2023-2028) & (USD Million)
Table 83. Europe Whole Genome and Exome Sequencing Revenue by Country (2017-2022) & (USD Million)
Table 84. Europe Whole Genome and Exome Sequencing Revenue by Country (2023-2028) & (USD Million)
Table 85. Asia-Pacific Whole Genome and Exome Sequencing Revenue by Type (2017-2022) & (USD Million)
Table 86. Asia-Pacific Whole Genome and Exome Sequencing Revenue by Type (2023-2028) & (USD Million)
Table 87. Asia-Pacific Whole Genome and Exome Sequencing Revenue by Application (2017-2022) & (USD Million)
Table 88. Asia-Pacific Whole Genome and Exome Sequencing Revenue by Application (2023-2028) & (USD Million)
Table 89. Asia-Pacific Whole Genome and Exome Sequencing Revenue by Region (2017-2022) & (USD Million)
Table 90. Asia-Pacific Whole Genome and Exome Sequencing Revenue by Region (2023-2028) & (USD Million)
Table 91. South America Whole Genome and Exome Sequencing Revenue by Type (2017-2022) & (USD Million)
Table 92. South America Whole Genome and Exome Sequencing Revenue by Type (2023-2028) & (USD Million)
Table 93. South America Whole Genome and Exome Sequencing Revenue by Application (2017-2022) & (USD Million)
Table 94. South America Whole Genome and Exome Sequencing Revenue by Application (2023-2028) & (USD Million)
Table 95. South America Whole Genome and Exome Sequencing Revenue by Country (2017-2022) & (USD Million)
Table 96. South America Whole Genome and Exome Sequencing Revenue by Country (2023-2028) & (USD Million)
Table 97. Middle East & Africa Whole Genome and Exome Sequencing Revenue by Type (2017-2022) & (USD Million)
Table 98. Middle East & Africa Whole Genome and Exome Sequencing Revenue by Type (2023-2028) & (USD Million)
Table 99. Middle East & Africa Whole Genome and Exome Sequencing Revenue by Application (2017-2022) & (USD Million)
Table 100. Middle East & Africa Whole Genome and Exome Sequencing Revenue by Application (2023-2028) & (USD Million)
Table 101. Middle East & Africa Whole Genome and Exome Sequencing Revenue by Country (2017-2022) & (USD Million)
Table 102. Middle East & Africa Whole Genome and Exome Sequencing Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Whole Genome and Exome Sequencing Picture
Figure 2. Global Whole Genome and Exome Sequencing Revenue Market Share by Type in 2021
Figure 3. Kits
Figure 4. Instruments
Figure 5. Whole Genome and Exome Sequencing Revenue Market Share by Application in 2021
Figure 6. Hospitals and Clinics Picture
Figure 7. Pharmaceutical and Biotechnology Companies Picture
Figure 8. Diagnostic Labs Picture
Figure 9. Research Centres, Academia and Government Institutes Picture
Figure 10. Others Picture
Figure 11. Global Whole Genome and Exome Sequencing Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global Whole Genome and Exome Sequencing Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Whole Genome and Exome Sequencing Revenue Market Share by Region (2017-2028)
Figure 14. Global Whole Genome and Exome Sequencing Revenue Market Share by Region in 2021
Figure 15. North America Whole Genome and Exome Sequencing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Europe Whole Genome and Exome Sequencing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Asia-Pacific Whole Genome and Exome Sequencing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. South America Whole Genome and Exome Sequencing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Middle East and Africa Whole Genome and Exome Sequencing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Whole Genome and Exome Sequencing Market Drivers
Figure 21. Whole Genome and Exome Sequencing Market Restraints
Figure 22. Whole Genome and Exome Sequencing Market Trends
Figure 23. Eurofins Scientific SE Recent Developments and Future Plans
Figure 24. Agilent Technologies, Inc Recent Developments and Future Plans
Figure 25. Beijing Genomics Institute (BGI) Recent Developments and Future Plans
Figure 26. Hoffmann-La Roche Ltd Recent Developments and Future Plans
Figure 27. Bio-Rad Laboratories, Inc Recent Developments and Future Plans
Figure 28. GENEWIZ, Inc Recent Developments and Future Plans
Figure 29. Illumina, Inc Recent Developments and Future Plans
Figure 30. Laboratory Corporation of America Holdings Recent Developments and Future Plans
Figure 31. Novogene Corporation Recent Developments and Future Plans
Figure 32. Oxford Nanopore Technologies, Inc Recent Developments and Future Plans
Figure 33. Pacific Biosciences of California, Inc Recent Developments and Future Plans
Figure 34. QIAGEN N.V Recent Developments and Future Plans
Figure 35. Thermo Fisher Scientific Inc Recent Developments and Future Plans
Figure 36. Cytiva Recent Developments and Future Plans
Figure 37. Global Whole Genome and Exome Sequencing Revenue Share by Players in 2021
Figure 38. Whole Genome and Exome Sequencing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 39. Global Top 3 Players Whole Genome and Exome Sequencing Revenue Market Share in 2021
Figure 40. Global Top 10 Players Whole Genome and Exome Sequencing Revenue Market Share in 2021
Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 42. Global Whole Genome and Exome Sequencing Revenue Share by Type in 2021
Figure 43. Global Whole Genome and Exome Sequencing Market Share Forecast by Type (2023-2028)
Figure 44. Global Whole Genome and Exome Sequencing Revenue Share by Application in 2021
Figure 45. Global Whole Genome and Exome Sequencing Market Share Forecast by Application (2023-2028)
Figure 46. North America Whole Genome and Exome Sequencing Sales Market Share by Type (2017-2028)
Figure 47. North America Whole Genome and Exome Sequencing Sales Market Share by Application (2017-2028)
Figure 48. North America Whole Genome and Exome Sequencing Revenue Market Share by Country (2017-2028)
Figure 49. United States Whole Genome and Exome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Canada Whole Genome and Exome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Mexico Whole Genome and Exome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Europe Whole Genome and Exome Sequencing Sales Market Share by Type (2017-2028)
Figure 53. Europe Whole Genome and Exome Sequencing Sales Market Share by Application (2017-2028)
Figure 54. Europe Whole Genome and Exome Sequencing Revenue Market Share by Country (2017-2028)
Figure 55. Germany Whole Genome and Exome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. France Whole Genome and Exome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. United Kingdom Whole Genome and Exome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Russia Whole Genome and Exome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Italy Whole Genome and Exome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Asia-Pacific Whole Genome and Exome Sequencing Sales Market Share by Type (2017-2028)
Figure 61. Asia-Pacific Whole Genome and Exome Sequencing Sales Market Share by Application (2017-2028)
Figure 62. Asia-Pacific Whole Genome and Exome Sequencing Revenue Market Share by Region (2017-2028)
Figure 63. China Whole Genome and Exome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Japan Whole Genome and Exome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South Korea Whole Genome and Exome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. India Whole Genome and Exome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Southeast Asia Whole Genome and Exome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Australia Whole Genome and Exome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. South America Whole Genome and Exome Sequencing Sales Market Share by Type (2017-2028)
Figure 70. South America Whole Genome and Exome Sequencing Sales Market Share by Application (2017-2028)
Figure 71. South America Whole Genome and Exome Sequencing Revenue Market Share by Country (2017-2028)
Figure 72. Brazil Whole Genome and Exome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Argentina Whole Genome and Exome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Middle East and Africa Whole Genome and Exome Sequencing Sales Market Share by Type (2017-2028)
Figure 75. Middle East and Africa Whole Genome and Exome Sequencing Sales Market Share by Application (2017-2028)
Figure 76. Middle East and Africa Whole Genome and Exome Sequencing Revenue Market Share by Country (2017-2028)
Figure 77. Turkey Whole Genome and Exome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Saudi Arabia Whole Genome and Exome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. UAE Whole Genome and Exome Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Methodology
Figure 81. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Eurofins Scientific SE Agilent Technologies, Inc Beijing Genomics Institute (BGI) Hoffmann-La Roche Ltd Bio-Rad Laboratories, Inc GENEWIZ, Inc Illumina, Inc Laboratory Corporation of America Holdings Novogene Corporation Oxford Nanopore Technologies, Inc Pacific Biosciences of California, Inc QIAGEN N.V Thermo Fisher Scientific Inc Cytiva
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
-
- Digging deeper into global industry information and providing market strategies.Contact Us >>